Russell Investments Group, Ltd. Biotechnology

Russell Investments Group, Ltd.

$69.8 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
RVNC Revance Therapeutics, Inc.	$212M	$5,000 0.0% of portfolio	2,278	Q4 2024 Added 1,050.51%
AADI Aadi Bioscience, Inc.	$58.6M	$4,000 0.0% of portfolio	1,512	Q3 2024 New
ARQT Arcutis Biotherapeutics, Inc.	$784M	$3,000 0.0% of portfolio	240	Q4 2024 Reduced 97.44%
ATXS Astria Therapeutics, Inc.	$103M	$3,000 0.0% of portfolio	385	Q3 2024 New
CABA Cabaletta Bio, Inc.	$59.8M	$3,000 0.0% of portfolio	1,574	Q4 2024 New
SVRA Savara Inc	$307M	$3,000 0.0% of portfolio	1,026	Q4 2024 New
SRRK Scholar Rock Holding Corp	$1.95B	$3,000 0.0% of portfolio	73	Q4 2024 Reduced 30.48%
SEER Seer, Inc.	$132M	$3,000 0.0% of portfolio	1,603	Q4 2024 Reduced 21.8%
THRD Third Harmonic Bio, Inc.	$140M	$3,000 0.0% of portfolio	343	Q3 2024 Reduced 12.28%
ABOS Acumen Pharmaceuticals, Inc.	$56.3M	$2,000 0.0% of portfolio	1,237	Q4 2024 New
BGNE Bei Gene, Ltd.	$23.5B	$2,000 0.0% of portfolio	14	Q4 2024 Reduced 99.9%
FENC Fennec Pharmaceuticals Inc.	$173M	$2,000 0.0% of portfolio	377	Q4 2024 Reduced 99.37%
REPL Replimune Group, Inc.	$689M	$2,000 0.0% of portfolio	241	Q4 2024 Reduced 99.18%
ALLO Allogene Therapeutics, Inc.	$312M	$1,000 0.0% of portfolio	587	Q4 2024 New
AVIR Atea Pharmaceuticals, Inc.	$257M	$1,000 0.0% of portfolio	504	Q4 2024 Reduced 54.26%
AURA Aura Biosciences, Inc.	$220M	$1,000 0.0% of portfolio	186	Q4 2024 Reduced 2.62%
COGT Cogent Biosciences, Inc.	$526M	$1,000 0.0% of portfolio	174	Q3 2024 Reduced 92.68%
CHRS Coherus Bio Sciences, Inc.	$83.2M	$1,000 0.0% of portfolio	743	Q4 2024 New
CRSP Crispr Therapeutics Ag	$3.74B	$1,000 0.0% of portfolio	50	Q3 2024 Reduced 80.0%
FULC Fulcrum Therapeutics, Inc.	$200M	$1,000 0.0% of portfolio	314	Q4 2024 Added 568.09%
PROK Prokidney Corp Ord Shs Cl A(Cy	$92.3M	$1,000 0.0% of portfolio	843	Q4 2024 Reduced 33.41%
PTGX Protagonist Therapeutics, Inc	$1.9B	$1,000 0.0% of portfolio	29	Q4 2024 Added 20.83%
TSVT 2seventy Bio, Inc.	$98.9M	$0 0.0% of portfolio	76	Q3 2024 Reduced 97.29%
ABSI Absci Corp	$461M	$0 0.0% of portfolio	238	Q4 2024 Reduced 82.96%
ALXO Alx Oncology Holdings Inc	$45.6M	$0 0.0% of portfolio	228	Q4 2024 Added 132.65%
ARCT Arcturus Therapeutics Holdings Inc.	$472M	$0 0.0% of portfolio	29	Q4 2024 Reduced 98.99%
BMEA Biomea Fusion, Inc.	$101M	$0 0.0% of portfolio	125	Q3 2024 New
CELC Celcuity Inc.	$196M	$0 0.0% of portfolio	14	Q1 2024 New
CLSD Clearside Biomedical, Inc.	$61.4M	$0 0.0% of portfolio	145	Q3 2024 Reduced 40.33%
CMPX Compass Therapeutics, Inc.	$296M	$0 0.0% of portfolio	193	Q4 2024 New
DAWN Day One Biopharmaceuticals, Inc.	$913M	$0 0.0% of portfolio	5	Q4 2024 Reduced 83.87%
IGMS Igm Biosciences, Inc.	$40M	$0 0.0% of portfolio	131	Q4 2024 Reduced 85.78%
IMCR Immunocore Holdings PLC	$1.31B	$0 0.0% of portfolio	30	Q2 2024 Reduced 57.75%
KMPH Kempharm, Inc	$170M	$0 0.0% of portfolio	176	Q4 2024 New
NVAX Novavax Inc	$625M	$0 0.0% of portfolio	52	Q3 2024 Reduced 95.98%
OCUL Ocular Therapeutix, Inc	$539M	$0 0.0% of portfolio	68	Q3 2024 New
OVID Ovid Therapeutics Inc.	$43.7M	$0 0.0% of portfolio	447	Q4 2024 Reduced 74.66%
PBYI Puma Biotechnology, Inc.	$133M	$0 0.0% of portfolio	20	Q2 2024 New
PYXS Pyxis Oncology, Inc.	$47M	$0 0.0% of portfolio	64	Q3 2024 New
RGLS Regulus Therapeutics Inc.	$19.2M	$0 0.0% of portfolio	458	Q4 2024 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	917	Q4 2024 Reduced 97.11%
VTYX Ventyx Biosciences, Inc.	$91M	$0 0.0% of portfolio	290	Q4 2024 Reduced 78.13%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.